LIPC — MultiTargetDB

Target Details

UniProt AC	`P11150`
Gene Symbol	LIPC
Protein Name	Hepatic triacylglycerol lipase
Organism	Homo sapiens
Entry Name
Organism Category	Human
Pfam Domains	PF00151 (Lipase) PF01477 (PLAT)

Summary

Multi-target molecules 243
Clinical molecules 0
Avg pChEMBL 7.26

KEGG Pathways (3)

Associated Diseases (1)

Hepatic lipase deficiency

Top Co-occurrence Targets

LIPG 243 shared
DAGLA 1 shared
ABHD6 1 shared
DAGLB 1 shared
ABHD12 1 shared
PLA2G7 1 shared
FASN 1 shared
PNLIP 1 shared
LPL 1 shared
ABHD16A 1 shared

Active Molecules (243)

InChIKey	pChEMBL	Type	Targets	Clinical
`HVLQWXXHYLOLCT`	6.5	IC50	2	—
`PPZQTLPDZUNGMS`	6.5	IC50	2	—
`CMDAMYPATGGNFR`	6.5	IC50	2	—
`GWSHIONDYCCNLF`	6.5	IC50	2	—
`KWLOXDMNTZUJNV`	6.5	IC50	2	—
`GPUYSECBAZQBNP`	6.5	IC50	2	—
`KFGPSLHSGSVLAZ`	6.5	IC50	2	—
`APFSOOZXMCXYSL`	6.5	IC50	2	—
`MPDNCAPXIWYHIY`	6.5	IC50	2	—
`ZVHFIVWRGOXJQL`	6.5	IC50	2	—
`IOMHIZCNNNHAQX`	6.5	IC50	2	—
`DTFGNAMGLLXARH`	6.4	IC50	2	—
`HJHZPDCHBCRLEZ`	6.4	IC50	2	—
`BGPIAIFBDLOQQB`	6.4	IC50	2	—
`CSUGNJQCVPWCCN`	6.4	IC50	2	—
`JJHPWLJWLANJOG`	6.4	IC50	2	—
`QPZMXKHRLIDMNM`	6.4	IC50	2	—
`RYZCDNIPOMVQAY`	6.4	IC50	2	—
`YHEHOXOWHALWNH`	6.4	IC50	2	—
`NNTCOWMPRPPKBD`	6.4	IC50	2	—
`LVXUCPYFNXPZRJ`	6.4	IC50	2	—
`VTGUKEFEIRIGHJ`	6.3	IC50	2	—
`RLRULPWNWKGBJK`	6.3	IC50	2	—
`KDXNZYNRYYPCDU`	6.3	IC50	2	—
`VJULUWPPORLTHQ`	6.3	IC50	2	—
`NSXOZBRRZUKDOS`	6.3	IC50	2	—
`RQSMMAZRERFAKF`	6.3	IC50	2	—
`CRHDSEBXIRSEMV`	6.2	IC50	2	—
`SESRKQBAGAEZQD`	6.2	IC50	2	—
`DSAZRYOHNSAOFC`	6.2	IC50	2	—
`DWRSQUWIAUDGHR`	6.2	IC50	2	—
`OIBQCUYNFNBXEL`	6.2	IC50	2	—
`ZOVKZXYGCYCJCC`	6.1	IC50	2	—
`KFLLVZORIUYQNO`	6.1	IC50	2	—
`RVXKMVONXPQBCS`	6.1	IC50	2	—
`ONHYIKFLNQDREW`	6.1	IC50	2	—
`XGWJWHGABKQDFY`	6.1	IC50	2	—
`SKZCHAMUXUZJPO`	6.1	IC50	2	—
`GPOHSBUAHXXTGW`	6.0	IC50	2	—
`KAFFNZFGJICJKK`	6.0	IC50	2	—
`RMJWVBVXDCLYKY`	6.0	IC50	2	—
`LOVYFHQVJWSQFH`	6.0	IC50	2	—
`SPIQOLQBCVMHIY`	6.0	IC50	2	—